Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis

ClinicalTrials.gov ID: NCT01475253

Public ClinicalTrials.gov record NCT01475253. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension

Study identification

NCT ID
NCT01475253
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Allergan
Industry
Enrollment
104 participants

Conditions and interventions

Interventions

  • Lidocaine Releasing Intravesical System - LiRIS® Drug
  • LiRIS Placebo Other
  • Sham Cystoscopy Procedure Procedure

Drug · Other · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2011
Primary completion
Nov 30, 2012
Completion
Nov 30, 2012
Last update posted
Sep 20, 2015

2011 – 2012

United States locations

U.S. sites
27
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
Clinical Trials of Arizona Glendale Arizona 85306
Citrus Valley Medical Research, Inc Glendora California 91741
Stanford University Department of Urology Stanford California 94306
Genitourinary Surgical Consultants Denver Colorado 80220
Women's Health Specialty Care Farmington Connecticut 06032
Grove Hill Clinical Research New Britain Connecticut 06052
Manatee Medical Research Institute, LLC Bradenton Florida 34205
North Idaho Urology Coeur d'Alene Idaho 83814
Idaho Urologic Center Meridian Idaho 83642
First Urology Jeffersonville Indiana 47130
Regional Urology LLC Shreveport Louisiana 71106
Lahey Clinic Medical Center Burlington Massachusetts 01805
Bay State Clinical Trials, Inc Watertown Massachusetts 02472
Female Pelvic Medicine & Urogynecology Grand Rapids Michigan 49503
William Beaumont Hospital Royal Oak Michigan 48073
CRC of Jackson and Southeast Urogynecology Jackson Mississippi 39202
Sheldon Freedman, MD Ltd Las Vegas Nevada 89148
Arthur Smith Institute for Urology New Hyde Park New York 11040
University of Rochester, Department of Urology Rochester New York 14642
Alliance Urology Specialists Greensboro North Carolina 27403
Wake Forest University Health Sciences Medical Center Winston-Salem North Carolina 27103
MetroHealth Medical Center Cleveland Ohio 44109
Penn. Presbyterian Medical Center Philadelphia Pennsylvania 19104
Medical University of South Carolina Urology Ambulatory Care Charleston South Carolina 29425
Carolina Urologic Research Center Myrtle Beach South Carolina 29572
Vanderbilt University Medical Center Nashville Tennessee 37232
Integrity Medical Research Mountlake Terrace Washington 98043

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01475253, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 20, 2015 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01475253 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →